To resolve this issue, recent genetically engineered fate-mapping study by Chen et al. identified F4/80 as a marker to distinguish tumor-infiltrating Mφs from resident microglia, monocytes and neutrophils, accounting for more than 80% of all CD45+CD11b+ myeloid lineage cells in GBM tissues [24]. Here, ITGAM is linked to neoplasm.